Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Compound derived from traditional Chinese medicine has antipsoriatic activity

Oct. 16, 2014

Cutaneous tolerability and therapeutic benefits of LAS-41010

Oct. 15, 2014

RAPID-PsA phase III results for certolizumab pegol in patients with active psoriasis

Oct. 15, 2014

Phase IIb data for dupilumab in patients with atopic dermatitis reported

Oct. 14, 2014

First-in-human results for BI-655066 in psoriasis

Oct. 13, 2014

Easy, safe and accurate local treatment of seborrheic keratosis lesions with BL-5010

Oct. 10, 2014

Amgen reports topline results from phase III study of adalimumab biosimilar in psoriasis

Oct. 9, 2014

E-6005 shows efficacy and safety in early clinical studies in patients with atopic dermatitis

Oct. 9, 2014

Foamix begins phase II trial of FDX-104 to prevent EGFR inhibitor-induced rash

Oct. 8, 2014

Biofrontera reports preliminary results from phase III trial of Ameluz

Oct. 6, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...